Fenofibrate
Rank #390 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$24.2M
Total Cost
670,936
Total Claims
$24.2M
Total Cost
24,023
Prescribers
$36
Cost per Claim
80,738
Beneficiaries
1,574,534
30-Day Fills
$1,008
Avg Cost/Provider
28
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$24.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $24.2M total
Top Prescribers of Fenofibrate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Vlad Nusinovich | Internal Medicine | West Hollywood, CA | 329 | $204K |
| 2 | Mikhail Chilingaryan | General Practice | Pittsburgh, PA | 598 | $196K |
| 3 | Arthur Karaguezian | Family Practice | Northridge, CA | 111 | $42K |
| 4 | Arutyun Topsakalyan | General Practice | Glendale, CA | 171 | $30K |
| 5 | Armen Kazanchian | Internal Medicine | Glendale, CA | 44 | $29K |
| 6 | Paula Henderson | Family Practice | Hemet, CA | 474 | $27K |
| 7 | Tri-Dung Hoang | Internal Medicine | Sacramento, CA | 451 | $27K |
| 8 | Roopal Desa | Internal Medicine | Conyers, GA | 50 | $26K |
| 9 | Rodolfo Protacio | Internal Medicine | Glendale, CA | 232 | $25K |
| 10 | Zinovy Lekht | Neurosurgery | Sun Valley, CA | 32 | $24K |
| 11 | Arkady Stern | Family Practice | Los Angeles, CA | 44 | $23K |
| 12 | Rachel Voeghtly | Nurse Practitioner | Altoona, PA | 124 | $21K |
| 13 | Rafael Armendariz | Family Practice | El Paso, TX | 494 | $20K |
| 14 | John Olson | Physician Assistant | Temecula, CA | 46 | $19K |
| 15 | Chau Le | Internal Medicine | Rosemead, CA | 280 | $18K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 387 | Pegfilgrastim (Neulasta) | $24.4M | 3,096 |
| 388 | Linagliptin/Metformin Hcl (Jentadueto) | $24.3M | 33,018 |
| 389 | Ocrelizumab (Ocrevus) | $24.2M | 639 |
| 390 | Fenofibrate (Fenofibrate) | $24.2M | 670,936 |
| 391 | Empaglifloz/Linaglip/Metformin (Trijardy Xr) | $23.9M | 28,001 |
| 392 | Fluticasone Furoate (Arnuity Ellipta) | $23.7M | 74,825 |
| 393 | Lactulose (Lactulose) | $23.6M | 538,677 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology